» Articles » PMID: 36002711

Investigation of the Predictive Factors of Diminished Ovarian Reserve in Women Aged Less Than 40 Years and Undergoing ICSI Cycle

Overview
Journal Reprod Sci
Publisher Springer
Date 2022 Aug 24
PMID 36002711
Authors
Affiliations
Soon will be listed here.
Abstract

Diminished ovarian reserve (DOR) is one of the primary causes of poor ICSI outcomes. Therefore, this study was performed to speculate which of the following parameters: AMH, AFC, and women's age can be used as a predictor factor of the DOR in women aged < 40 years. This prospective study enrolled 500 women suffering from idiopathic infertility problems and who underwent GnRH antagonist multiple-dose stimulation protocol. The women were divided into two groups: normal fertility (FSH ≤ 10 mIU/mL, n = 300) and DOR (FSH > 10 mIU/mL, n = 200). At the time of the study, the average of women age was 29.3 ± 5.7 years. A significant reduction was found in AMH level, AFC, number of mature, immature oocytes, fertilized oocytes, embryos transferred, and β-hCG level in the DOR group compared to the normal fertility group (P < 0.001). Conversely, a significant increase was shown in the age of the DOR group compared to the normal fertility group (30.8 ± 5.8 vs. 28.2 ± 5.4, respectively; P < 0.001). A significant negative association was found between the AFC, the number of mature oocytes, fertilized oocytes, embryos transferred, and the basal level of FSH in the DOR group (P < 0.01). The receiver operating characteristics (ROC) demonstrated that AMH level and AFC had the highest accuracy, followed by age in the prediction of DOR (P < 0.001) with a cut-off value of ≤ 1.2 ng/mL, ≤ 4.5, and > 29.5 years, respectively. This study exhibited that the levels of AMH and AFC are the best biomarkers, followed by age for the prediction of DOR in women < 40 years old. Furthermore, AMH is the only independent factor that is significantly related to DOR in women.

Citing Articles

The best ovarian reserve marker to predict ovarian response following controlled ovarian hyperstimulation: a systematic review and meta-analysis.

Salemi F, Jambarsang S, Kheirkhah A, Salehi-Abargouei A, Ahmadnia Z, Hosseini H Syst Rev. 2024; 13(1):303.

PMID: 39695880 PMC: 11657140. DOI: 10.1186/s13643-024-02684-0.


The usefulness of peri-trigger female reproductive hormones (delta-FRH) in predicting oocyte maturation in normal ovarian reserve patients who received fertilization-embryo transfer: a retrospective study.

He L, Xu Q, Wan F, Hao L, Qiu Y, Ran X PeerJ. 2024; 12:e17706.

PMID: 39006021 PMC: 11246619. DOI: 10.7717/peerj.17706.


Predictive Factors for the Formation of Viable Embryos in Subfertile Patients with Diminished Ovarian Reserve: A Clinical Prediction Study.

Feng K, Zhang Z, Wu L, Zhu L, Li X, Li D Reprod Sci. 2024; 31(6):1747-1756.

PMID: 38409494 PMC: 11111567. DOI: 10.1007/s43032-024-01469-z.

References
1.
El-Toukhy T, Khalaf Y, Hart R, Taylor A, Braude P . Young age does not protect against the adverse effects of reduced ovarian reserve--an eight year study. Hum Reprod. 2002; 17(6):1519-24. DOI: 10.1093/humrep/17.6.1519. View

2.
Cooper A, Baker V, Sterling E, Ryan M, Woodruff T, Nelson L . The time is now for a new approach to primary ovarian insufficiency. Fertil Steril. 2010; 95(6):1890-7. PMC: 2991394. DOI: 10.1016/j.fertnstert.2010.01.016. View

3.
Pastore L, Christianson M, Stelling J, Kearns W, Segars J . Reproductive ovarian testing and the alphabet soup of diagnoses: DOR, POI, POF, POR, and FOR. J Assist Reprod Genet. 2017; 35(1):17-23. PMC: 5758472. DOI: 10.1007/s10815-017-1058-4. View

4.
Greene A, Patounakis G, Segars J . Genetic associations with diminished ovarian reserve: a systematic review of the literature. J Assist Reprod Genet. 2014; 31(8):935-46. PMC: 4130940. DOI: 10.1007/s10815-014-0257-5. View

5.
Tufan E, Elter K, Durmusoglu F . Assessment of reproductive ageing patterns by hormonal and ultrasonographic ovarian reserve tests. Hum Reprod. 2004; 19(11):2484-9. DOI: 10.1093/humrep/deh448. View